IntelGenx Technologies grants options to acquire 125,000 common shares

Dec 5 2009NewsGuard 100/100 Score

IntelGenx Technologies Corp. ("IntelGenx") (TSX VENTURE:IGX)(OTCBB:IGXT) announced today that the Company's board of directors granted options to acquire 125,000 common shares effective November 24, 2009. All options were granted under the 2006 Stock Option Plan with an exercise price of C$0.65 and expire in five years.

Of the total stock options grant, 25,000 were granted to each of the Company's non employee directors Bernard Boudreau, Ian Troup and Bernd Melchers and vest immediately. The company also granted 25,000 options to purchase common shares to each the CEO and President, Horst G. Zerbe and the CFO, Paul A. Simmons. The officer's options vest over the period of two years at the rate of 25 % every six months.

Source: IntelGenx Corp.

Posted in:

Tags: , ,

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback